Prins M, Veugelers P J
Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands.
AIDS. 1997 Apr;11(5):621-31. doi: 10.1097/00002030-199705000-00010.
To compare the progression and non-progression of HIV infection among 418 injecting drug users (IDU) and 422 homosexual men with documented dates of HIV seroconversion from 12 cohorts.
Seroconversion dates were calculated for each subject using a cohort-specific estimate of the cumulative HIV seroincidence over calendar time. In survival analysis, we studied the progression from seroconversion to AIDS and death by risk group. We compared non-progression between both risk groups by evaluating annual CD4 decline over the 7 years following seroconversion among AIDS-free subjects.
The relative hazard (RH) of AIDS for homosexual men compared with IDU was 1.54 before, and 1.21 after, adjusting for age at seroconversion and year of seroconversion. The risk of death from any cause for homosexual men compared with IDU increased over time since seroconversion. Fifty IDU died prior to AIDS, compared with seven homosexual men (unadjusted RH for homosexual men 0.10). Ignoring this pre-AIDS mortality, the crude RH of death for homosexual men compared with IDU was 2.05. Alter adjusting for age at seroconversion and year of seroconversion in multivariate analysis, the RH became 1.42. No differences in progression between subgroups aged 24 years or older could be demonstrated, but subjects < 24 years were found to be at a decreased risk. Proportions of non-progressors based on CD4 slope > or = 0 at 7 years following seroconversion were higher for IDU than for homosexual men. No differences were found in the proportion (approximately 5%) classified as non-progressors by criteria of both slope > or = 0 and absolute CD4 counts > 500 cells x 10(6)/l, even if pre-AIDS deaths and losses to follow-up were included.
We found little evidence for an effect of risk group on progression and non-progression. Pre-AIDS mortality was much higher among IDU than homosexual men. Pre-AIDS mortality and a nonlinear age effect should be considered in planning interventions as well as studies comparing risk groups and modelling the epidemic.
比较418名注射吸毒者(IDU)和422名男同性恋者中HIV感染的进展和非进展情况,这些人来自12个队列,有记录的HIV血清转化日期。
使用特定队列对日历时间内累积HIV血清发病率的估计值,为每个受试者计算血清转化日期。在生存分析中,我们按风险组研究了从血清转化到艾滋病和死亡的进展情况。我们通过评估血清转化后7年内无艾滋病受试者的年度CD4下降情况,比较了两个风险组之间的非进展情况。
在调整血清转化时的年龄和血清转化年份后,男同性恋者与IDU相比,患艾滋病的相对风险(RH)在调整前为1.54,调整后为1.21。自血清转化以来,男同性恋者与IDU相比,任何原因导致的死亡风险随时间增加。50名IDU在患艾滋病之前死亡,而男同性恋者为7名(男同性恋者未调整的RH为0.10)。忽略这种艾滋病前死亡率,男同性恋者与IDU相比,死亡的粗RH为2.05。在多变量分析中调整血清转化时的年龄和血清转化年份后,RH变为1.42。在24岁及以上的亚组之间未发现进展差异,但发现年龄<24岁的受试者风险降低。血清转化后7年时,根据CD4斜率≥0确定的非进展者比例,IDU高于男同性恋者。即使纳入艾滋病前死亡和失访情况,根据斜率≥0和绝对CD4计数>500个细胞×10⁶/L标准分类为非进展者的比例(约5%)也未发现差异。
我们几乎没有发现风险组对进展和非进展有影响的证据。IDU中的艾滋病前死亡率远高于男同性恋者。在规划干预措施以及比较风险组和模拟疫情的研究中,应考虑艾滋病前死亡率和非线性年龄效应。